









Markets
/
Stocks
/
nasdaq-syk
/

Stryker Corp

SYK

354.300USD

-3.530-0.99%

Close 01/29, 16:00（ET）Quotes delayed by 15 min

135.48BMarket Cap

45.99P/E TTM



Stryker Corp

354.300

-3.530-0.99%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Stryker Corp

Currency: USD Updated: 2026-01-29

Key Insights

Stryker Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 426.19.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stryker Corp's Score

Industry at a Glance

Industry Ranking

25 / 205

Overall Ranking

103 / 4540

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Stryker Corp Highlights

StrengthsRisks

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 22.47% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 22.59B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 41.30%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 41.30%.

Fairly Valued

The company’s latest PE is 45.99, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 313.23M shares, decreasing 1.44% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 9.43K shares of this stock.

Analyst Rating

Based on 32 analysts

Buy

Current Rating

426.192

Target Price

+20.20%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-29

The current financial score of Stryker Corp is 8.70, ranking 32 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 6.06B, representing a year-over-year increase of 10.25%, while its net profit experienced a year-over-year increase of 3.00%.

Score

Industry at a Glance

Previous score

8.70

Change



Financials

7.19

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.78

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.62

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.75

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.17

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Stryker Corp's Company Valuation

Currency: USD Updated: 2026-01-29

The current valuation score of Stryker Corp is 6.29, ranking 166 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 45.99, which is 14.78% below the recent high of 52.78 and 24.24% above the recent low of 34.84.

Score

Industry at a Glance

Previous score

6.29

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 25/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-29

The current earnings forecast score of Stryker Corp is 8.13, ranking 57 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 435.00, with a high of 465.00 and a low of 317.70.

Score

Industry at a Glance

Previous score

8.13

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 32 analysts

Buy

Current Rating

426.192

Target Price

+20.20%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Medtronic PLC

MDT

Zimmer Biomet Holdings Inc

ZBH

Insulet Corp

PODD

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-29

The current price momentum score of Stryker Corp is 7.08, ranking 67 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 368.58 and the support level at 342.33, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.28

Change

-0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-1.171

Sell

RSI(14)

44.928

Neutral

STOCH(KDJ)(9,3,3)

34.132

Neutral

ATR(14)

7.025

High Vlolatility

CCI(14)

-87.201

Neutral

Williams %R

79.354

Sell

TRIX(12,20)

0.008

Sell

StochRSI(14)

5.235

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

355.744

Sell

MA10

358.621

Sell

MA20

359.006

Sell

MA50

359.467

Sell

MA100

365.733

Sell

MA200

374.292

Sell

Institutional Confidence

Currency: USD Updated: 2026-01-29

The current institutional shareholding score of Stryker Corp is 7.00, ranking 82 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 81.91%, representing a quarter-over-quarter increase of 0.52%. The largest institutional shareholder is The Vanguard, holding a total of 33.62M shares, representing 8.79% of shares outstanding, with 2.07% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

33.62M

+0.80%

Brown (John W)

20.06M

Greenleaf Trust

16.64M

-0.27%

BlackRock Institutional Trust Company, N.A.

16.26M

+1.13%

State Street Investment Management (US)

14.94M

-0.09%

T. Rowe Price Associates, Inc.

Star Investors

10.48M

-7.98%

Geode Capital Management, L.L.C.

7.47M

+0.98%

JP Morgan Asset Management

7.14M

-3.15%

AllianceBernstein L.P.

6.34M

+13.25%

Capital Research Global Investors

6.27M

-7.28%

Risk Assessment

Currency: USD Updated: 2026-01-29

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Stryker Corp is 9.56, ranking 6 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.88. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.